Royalty Pharma plc - Class A — Quarterly Cash Flow (NASDAQ:RPRX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 18.04 B18.22 B17.61 B18.32 B19.35 B19.62 B Total liabilities 7.78 B7.88 B7.82 B8.82 B9.73 B9.91 B Total equity 10.26 B10.34 B9.79 B9.5 B9.62 B9.71 B Total liabilities & shareholders' equities 18.04 B18.22 B17.61 B18.32 B19.35 B19.62 B Total debt —————— Net debt ——————

뉴스

TD Cowen, Royalty Pharma 목표 주가 $50로 상향 조정

TD Cowen raises Royalty Pharma stock price target to $50 on growth

로열티 파마, 주당 46.14달러로 52주 신고가 경신

Royalty Pharma stock hits 52-week high at 46.14 USD

Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)

The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com

Dividend Champion, Contender, And Challenger Highlights: Week Of February 15

로열티 파마, BofA 증권 ’매수’ 등급 재확인, 목표가 $54

Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript

Royalty Pharma stock hits 52-week high at 44.94 USD

Royalty Pharma Q4 2025 slides: double-digit growth amid synthetic royalty expansion

Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q4 Earnings